Görev Unvanı

Görev Yeri

Yıl

Araş. Gör.

 Tıp Fakültesi Kocaeli Üniversitesi

1996-2001

Araş. Gör.

 Tıp Fakültesi Hacettepe Üniversitesi

2001-2008

Yrd. Doç. Dr.

 Tıp Fakültesi Ordu Üniversitesi

200-2012

Doç. Dr.

Tıp Fakültesi Ordu Üniversitesi

2012-

 
  1. Uluslararası hakemli dergilerde yayımlanan makaleler :

A1. Bayrak T, Dursun P, Bayrak A, Gültekin M, Kolusarı A, Çakır E, Ozyurt M, Zeyneloğlu H.B. Paraoxonase Lactonase Activity (PON-HTLase), Asymmetric Dimethylarginine (ADMA) and Platelet Activating Factor-Acetylhydrolase (PAF-AH) Activity in Non-Obese women with PCOS. Gynecological Endocrinology. 2012:28;874-878. DOI: 10.3109/09513590.2012.683068.

A1. Bayrak A, Bayrak T, Volkan-Salancı B, Deniz A, Yavuz B, Tokgözoğlu S.L, Alikaşifoğlu M, Demirpençe E. Serum PON1 Activity but not Q192R Polymorphism is related to the Extent of Atherosclerosis. J Atheroscler Thromb. 2012;19(4):376-384. DOI:10.5551/jat.11320

A2. Bayrak T, Bayrak A, Volkan-Salancı B, Deniz A, Tokgözoğlu S.L, Yavuz B, Alikaşifoğlu M, Demirpençe E. Relationship of PON2 gene polymorphism and serum paraoxonase activity with coronary artery disease in Turkish population. Turk J Biochem. 2012;37(2):150-155. DOI: 10.5505/tjb.2012.83097.

A3. Bayrak T, Dursun P, Bayrak A, Gültekin M, Kolusarı A, Çakır E, Ozyurt M, Zeyneloğlu H.B. Paraoxonase Lactonase Activity (PON-HTLase), Asymmetric Dimethylarginine (ADMA) and Platelet Activating Factor-Acetylhydrolase (PAF-AH) Activity in Non-Obese women with PCOS. Gynecological Endocrinology. DOI: 10.3109/09513590.2012.683068.

A4. Bayrak A, Bayrak T, Demirpençe E, Kılınç K. Differential hydrolysis of homocysteine thiolactone by purified human serum 192Q and 192R PON1 isoenzymes J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(1):49-55.

A5. Bayrak T, Bayrak A, Demirpençe E, Kılınç K. Purification of rabbit liver paraoxonase 1 and investigation of its kinetic properties. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(21):1791-5

A6. Soyman Z, Noyan V, Tulmac M, Yucel A, Sagsoz N, Bayrak T, Bayrak A, Cakir E. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome. Fertil Steril. 2011;95(3):1067-72.

A7. Akbıyık F, Çevik S, Bayrak T, Doğan A.L, Bayrak A, Demirpençe E. Karaciğer hücre dizilerinde PON1 ekspresyonu ve aktivitesinin PPARalfa ligandları ile kontrolü. Turkish Journal of Biochemistry. 2010, 35(2): 151-156.

A8. Bayrak A, Aldemir D, Bayrak T, Çorakçı A, Dursun P. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Arch Gynecol Obstet 2006;274(5):289-96.

A9. Dursun P, Demirtaş E, Bayrak A, Yarali H. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Human Reproduction 2006;21;104-108.doı:  10.1093/humrep/dei284

A10. Yağmurdur H, Çakan T, Bayrak A, Arslan M, Baltacı B, İnan N, Kılınç K. The effects of etomidate, thiopental, and propofol in induction on hypoperfusion-reperfusion phenomen during laporoscopic cholecystomy. Acta Anaesthesiol Scand 2004;48:772-777.

Doı: 10.1111/j.0001-5172.2004.00417.x

A11. Solaroğlu A, Dede FS, Okutan E, Bayrak A, Haberal A, Kılınc K. A single dose of erythropoietin attenuates lipid peroxidation in experimental liver ischemia-reperfusion injury in the rat fetus. J Matern Fetal Neonatal Med 2004;16(4):231-4.

B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler:

B1. Bayrak T, Bayrak A, Demirpençe E, Kılınç K. Purification of rabbit liver paraoxonase 1 and investigation of its kinetic properties. FEBS Journal 2009, 276(S1):135.

B2. Bayrak A, Bayrak T, Demirpençe E, Kılınç K. Purification of human serum paraoxonase 1 and investigation of its kinetic properties. FEBS Journal 2009, FEBS Journal 2009, 276(S1):135.

B3. Bayrak A, Bayrak T, Demirpençe E, Kılınç K. Antioxidant Effects of Purified Liver and Serum Paraoxonase1 Enzymes. Turk J Biochem. Congress Special Issue 2009;34:178.

B4. Bayrak T, Deniz A, Tokgözoğlu L, Yavuz B, Demirpençe E, Bayrak A, Kılınc K, Salancı V.B, Kaşifoğlu M, Tuncbilek E. Evaluation of Paraoxonase-1 Gene Polymorphism and Serum Paraoxonase Activity as a Cardiovascular Risk. 77th Congress of the European Atherosclerosis Society Atherosclerosis Suppl 2008:9;106.

B5. Bayrak T, Çevik S, Bayrak A, Akbıyık F, Demirpençe E. PPAR-α Ligands Increase PON1 activity ın Hepatoma Cell Lines. Turk J Biochem. Congress Special Issue 2008;33:S249-S250

B6. Bayrak T, Deniz A, Bayrak A, Salancı V.B, Tokgözoğlu L, Kaşifoğlu M, Demirpençe E. Serum Paraoxonase-1 Activity but not Q192R Polimorphism is Related to the Extent of Atherosclerosis. Turk J Biochem. Congress Special Issue 2008;33:S242-S243

B7.Dursun P, Bayrak A, Gültekin M, Bayrak T, Aksu T. Effect of Transdermal estrogen therapy on serum paraoxonase activity in hysterectomized postmenapausal women. Fertility and Sterility 2007;88, S244 - S245.

B8. Bayrak T, Bayrak A, Yavuz B, Deniz A, Tokgözoğlu L, Demirpençe E. Serum paraoxonase activity in patients with coronary artery disease: a preliminary study. The Febs Journal 2006;273(S1):213

B9. Bayrak A, Aldemir D, Bayrak T, Dursun P, Çorakçı A. The Effect of hormone replacement therapy on the levels of serum lipids, Apo AI, Apo B and lipoprotein (a) in Turkish postmenapausal women. The Febs Journal 2006;273(S1):213

B10. Deniz A, Hazirolan T, Yavuz B, Tokgozoglu L, Duzguncinar O, Demirpence E, Bayrak T, Bayrak A, Aytemir K. Coronary calcium score is associated with blood myeloperoxidase level. Atherosclerosis Suppl. 2006;7:269.

B11. Yavuz B, Deniz A, Tokgozoglu L, Duzguncinar O, Demirpence E, Bayrak T, Bayrak A, Aytemir K. Increased myeloperoxidase level in coronary artery disease and its relationship with severity of the disease. Atherosclerosis 2006;7:524.

B12. Dursun P, Demirtaş E, Basaran M. Bayrak A, Yarali H. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Fertility and Sterility 2004;82,S300 – S301.

B13. Hergenc G, Ozsullu T, Uzun A, Cetinalp P, Bayrak A, Maral H. Kocaeli lipid study Atherosclerosıs 1999;146:31(1).

C. Yazılan uluslararası kitaplar veya kitaplarda bölümler:

D. Ulusal hakemli dergilerde yayımlanan makaleler :

D1. Bayrak T, Bayrak A, Demirpençe E, Kılınç K. Yeni bir kardiyovasküler belirteç adayı: paraoksonaz. Hacettepe Tıp Dergisi. 2006;36(3):147-151.

D2. Özsüllü T, Bayrak A. Büyükbeşe E. İnsülin benzeri büyüme faktörleri ve IGF Bağlayıcı Proteinler. Sendrom 1999:(7):20-23.

D3. Uzun A, Özsüllü T, Hergenç G, Maral H, Bayrak A, Çetinalp P. Coronary heart disease risk assessment in Kocaeli region. Kocaeli Üniversitesi Tıp Fakültesi Dergisi. 1997:(2):39-42.

E. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler:

E1. Bayrak T, Çevik S, Bayrak A, Akbıyık F, , Doğan A.L, Demirpençe E. PPAR-α Ligands

increased PON1 Activity and PON1 expression in MH7777A cell line. Spetses Summer School on Nuclear Receptor Signaling. August, 2009, Spetses Greece.

E2. Bayrak T, Bayrak A, Yavuz B, Deniz A, Tokgözoğlu L, Demirpençe E. Serum Paraoxonase activity is decreased in patients with coronary artery disease. 2nd International Conference on Paraoxonases. 7-10 September 2006 Hajduszoboszlo, Hungary.

E3. Bayrak A, Bayrak T, Dursun P, Demirtaş E, Yarali H. Serum paraoxonase activity is decreased in patients with polycystic ovary syndrome. 2nd International Conference on Paraoxonases. 7-10 September 2006 Hajduszoboszlo, Hungary.

E4. Bayrak A, Dursun P, Bayrak T, Aksu T. Effect of age on serum paraoxonase activity in Turkish premenopausal women. 2nd International Conference on Paraoxonases. 7-10 September 2006 Hajduszoboszlo, Hungary.

E5. Dursun P, Gültekin M, Bayrak A, Bozdağ G, Esinler D, Aksu T. Effect of HRT on Malondialehyde (MDA) levels in Postmenapausal Women. Gynecology and Obstetrics 2005;10(S):271

E6. Dağdelen S, Bayrak T, Harmancı A, Bayrak A, Gürlek A. Serum Paraoxonase Activity In Hashimotı’s Throiditis.7th European Congress of Endocrinology. 3-7 September 2005 Göteborg Sweden

E7. Bayrak A, Aldemir D, Bayrak T. Effects of Menaspouse and Hormone Replacement Therapy on Lipid Profile, Antioxidant Systems and Trace Elements Zn and Cu. Biomed 2004 11. International Biomedical science and Tecnology days. September 6-10, 2004.

E8. Bayrak T, Bayrak A, Hergenç G. Does exercise have favorable effects on blood lipids, HDL-Cholesterol, oxidant- antioxidant status and coronary heart disease risk factors in young Turkish men? Biomed 2004 11. International Biomedical science and Tecnology days. September 6-10, 2004.

E9. Bayrak A, Akaydin D, Çorakci A, Barutcu B, Vural F. Menapoz ve Hormon Replasman Tedavisinin Kan Lipid Etkisi. The first congress of Atherosclerosis Congress 19-20 March 1999 Izmir, Turkey.

E10. Bayrak A, Akaydin D, Corakci A, Barutcu B. Menapoz ve Hormon Replasman Tedavisinin Lipid peroksidasyonu, Antioksidanlar ve Bakır, Çinko Düzeylerine Etkisi. The first congress of Balkan association of Biosciences XV th National Congress of Biochemistry, Clinical Laboratory Automation Symposium-II 20-24 April 1999 Antalya, Turkey.

E11. Hergenç G, Beşoluk Ş, Özsüllü T, Çetinalp P, Bayrak A, Omay O,  Sönmez B. Lp(a) as a Risk Factor ın Coronary Heart Disease. Balkan Journal of Clinical Laboratory 1999;9:86